| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/31/2005 | DE10341043A1 Neue oral zu applizierende Darreichungsform für New dosage form for oral administration for 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester und dessen Salze and its salts |
| 03/31/2005 | CA2805552A1 Thyroid hormone analogs and methods of use in angiogenesis |
| 03/31/2005 | CA2540172A1 Liquid human growth hormone formulation containing polyethylene glycol |
| 03/31/2005 | CA2540129A1 Pharmaceutical delivery system |
| 03/31/2005 | CA2540105A1 Enteric soft gelatin capsule containing esomeprazole and method of preparation |
| 03/31/2005 | CA2539799A1 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same |
| 03/31/2005 | CA2539637A1 Coated tablets |
| 03/31/2005 | CA2539324A1 Transscleral delivery |
| 03/31/2005 | CA2539288A1 Thyroid hormone analogs and methods of use |
| 03/31/2005 | CA2539182A1 Chronotherapeutic dosage forms |
| 03/31/2005 | CA2539071A1 Disinfectant, antibiotic and anesthetic containing device for injections and incisions |
| 03/31/2005 | CA2539051A1 Delayed release dosage forms |
| 03/31/2005 | CA2538867A1 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| 03/31/2005 | CA2538527A1 Fluid medication delivery device |
| 03/31/2005 | CA2538064A1 Antibiotic product, use and formulation thereof |
| 03/31/2005 | CA2537080A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 03/31/2005 | CA2536609A1 Anhydrous topical formulation for polyphenols |
| 03/31/2005 | CA2528095A1 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
| 03/30/2005 | EP1518937A1 Increasing the concentration of a nucleic acid molecule |
| 03/30/2005 | EP1518583A1 Injectable active micro-tanks for medical substances |
| 03/30/2005 | EP1518555A1 Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 03/30/2005 | EP1518552A1 Fish gelatin hard capsule and its preparation method |
| 03/30/2005 | EP1518551A1 Solid dosage form comprising caffeine |
| 03/30/2005 | EP1518550A2 Bioadhesive drug delivery systems comprising poly(fumaric-co-sebacic acid) |
| 03/30/2005 | EP1518549A1 A pellet comprising a local anesthetic agent and a radiopaque material |
| 03/30/2005 | EP1518517A2 Drug-delivery endovascular stent and method for treating restenosis |
| 03/30/2005 | EP1518330A1 Filters for combined radiotelephone/gps terminals |
| 03/30/2005 | EP1517981A2 Stabilization of granules |
| 03/30/2005 | EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 03/30/2005 | EP1517746A1 Method of encapsulating hydrophobic organic molecules in polyurea capsules |
| 03/30/2005 | EP1517709A1 Transdermal drug delivery system |
| 03/30/2005 | EP1517699A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 03/30/2005 | EP1517697A1 Acidic insulin preparations with improved stability |
| 03/30/2005 | EP1517690A1 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 03/30/2005 | EP1517683A1 Sustained release tablet containing indapamide |
| 03/30/2005 | EP1517678A2 Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
| 03/30/2005 | EP1517677A1 Popping oral administration form |
| 03/30/2005 | EP1517676A1 Oral dosage forms comprising fenofibrate |
| 03/30/2005 | EP1517675A1 Composition for treatment of inflammatory disorders |
| 03/30/2005 | EP1517674A2 Preparations for the intranasal application of selected cgrp antagonists derived from amino acids and a method for their production |
| 03/30/2005 | EP1517673A1 Nasal composition comprising a mucopolysaccharide and propylene glycol |
| 03/30/2005 | EP1517672A1 Compositions and methods for amelioration of human female sexual dysfunction |
| 03/30/2005 | EP1517671A2 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 03/30/2005 | EP1517617A1 Compressed chewing gum |
| 03/30/2005 | EP1450770B1 Pharmaceutical composition comprising a 5ht1 receptor agonist |
| 03/30/2005 | EP1436607B1 Ion-sensitive field effect transistor and a method for producing a transistor of this type |
| 03/30/2005 | EP1436007B1 Compounds for use as surfactants |
| 03/30/2005 | EP1401401B1 Method for high through put screening using a small scale mill or microfluidics |
| 03/30/2005 | EP1399136B1 Process for the preparation of dispersions |
| 03/30/2005 | EP1397125B1 Compressible guaifenesin compositions and method for producing them |
| 03/30/2005 | EP1390037A4 Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 03/30/2005 | EP1389909A4 Antimicrobial compounds and methods for their use |
| 03/30/2005 | EP1383692B1 Packaging system for transdermal drug delivery systems |
| 03/30/2005 | EP1365704A4 Radiation cross-linked hydrogels |
| 03/30/2005 | EP1322350B1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 03/30/2005 | EP1307182B1 Pharmaceutical composition for transdermal delivery of befloxatone |
| 03/30/2005 | EP1250133B1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| 03/30/2005 | EP1250132B1 Ibuprofen containing active agent preparation |
| 03/30/2005 | EP1248597B1 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| 03/30/2005 | EP1246692B1 Templating of uncharged solid particles by polymer multilayers |
| 03/30/2005 | EP1237551B1 Pharmaceutical formulations containing zolmitriptan |
| 03/30/2005 | EP1194140B1 Pharmaceutical composition containing fenofibrate and preparation method |
| 03/30/2005 | EP1191926B1 New omeprazole and (s)-omeprazole formulation |
| 03/30/2005 | EP1185294B1 Peptides for the treatment of impaired interpersonal and behavioral disorders |
| 03/30/2005 | EP1181035B1 Substantially oil-free cyclosporin compositions |
| 03/30/2005 | EP1108423B1 Powdery pernasal compositions |
| 03/30/2005 | EP1035844B1 The use of polyols in combating yeast infection and polyol preparations for said use |
| 03/30/2005 | EP1005324B1 Compositions for delivery of biological agents and methods for the preparation thereof |
| 03/30/2005 | EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders |
| 03/30/2005 | EP0929232B1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 03/30/2005 | EP0922464B1 Quickly disintegrable compression-molded materials and process for producing the same |
| 03/30/2005 | EP0821584B1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection |
| 03/30/2005 | EP0817613B1 Use of compositions comprising stabilized enzymes |
| 03/30/2005 | EP0804194B1 Use of retinoic acid receptor-agonists or ap-1 antagonists for the manufacture of a medicament for preventing proliferation of retinal pigment epithelium |
| 03/30/2005 | EP0778771B1 Topical ketoconazole emulsions |
| 03/30/2005 | CN1602326A Lipid-polymer-conjugates |
| 03/30/2005 | CN1602216A Microprojection array immunization patch and method |
| 03/30/2005 | CN1602210A Prodn of dialysis concentrate from highly densified concentrate precursouand device for using on site of dialysis |
| 03/30/2005 | CN1602206A Pharmaceutical compositions based on azetidine derivatives |
| 03/30/2005 | CN1602205A Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions |
| 03/30/2005 | CN1602189A Composition comprising cysteamine for improving lactation in dairy animals |
| 03/30/2005 | CN1602188A Process for making pre-formed objects |
| 03/30/2005 | CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution |
| 03/30/2005 | CN1602186A Prolonged release biodegradable microspheres and method for preparing same |
| 03/30/2005 | CN1600755A General flavones of hawthorn fruit, preparation method and application |
| 03/30/2005 | CN1600674A Nano composite inorganic semiconductor hollow ball and preparation method |
| 03/30/2005 | CN1600360A Soft capsule of decoction of four ingredients possessing effect of enriching blood and regulating menstruation and preparation method |
| 03/30/2005 | CN1600359A Capsule for curing high blood fat and preparation method |
| 03/30/2005 | CN1600358A Combination of medication for curing hyperlipemia, arteriosclerosis, coronary heart disease and fatty liver |
| 03/30/2005 | CN1600357A Effective position of pilose asiabell root, preparation, medication use and preparation method |
| 03/30/2005 | CN1600354A Granule of compound eupatorium |
| 03/30/2005 | CN1600350A Capsule of activating the channels for cervical vertebrae |
| 03/30/2005 | CN1600349A Capsule prepared from cicada for soothing the nerves at night |
| 03/30/2005 | CN1600345A Ointment for quick curing trauma of burn and scald |
| 03/30/2005 | CN1600343A External remedy for curing scapulohumeral periarthritis |
| 03/30/2005 | CN1600342A External remedy for curing common cold |
| 03/30/2005 | CN1600340A External remedy for curing pain of lower back and leg |
| 03/30/2005 | CN1600339A A plaster for curing rheumatoid arthritis |
| 03/30/2005 | CN1600337A A plaster for curing hyperosteogeny |
| 03/30/2005 | CN1600334A Dedicated Chinese traditional medicine for curing gastric disease |